Three types of vaccine have been shown to be completely protective against the Zika virus.
Scientists found all three offered protection in tests on rhesus monkeys.
Zika virus has been deemed a public health emergency, because it can cause serious birth defects.
Photo AFP/Getty Images
Teams around the world are working to design a vaccine that can be given to people, but it is likely to be years before any is ready for widespread use.
More than 60 countries and territories now have continuing transmission of Zika virus, which is carried by mosquitoes.
The scientists in this latest study used three different approaches often used in vaccine development – one was an inactive, and therefore harmless, replica of the virus and two others used parts of the Zika virus’s genetic code.
All three offered complete protection and none were linked to major side-effects.
American scientists, including experts from the military, say their results mark a further promising step forward in the search for a jab against the Zika virus.
The next step will be early trials, possibly later this year, to establish that the vaccine is safe and effective in humans.
Brazil expects to develop a vaccine for the Zika virus in about a year, health officials say.
However, two more years would be needed for any large-scale rollout, health minister Marcelo Castro said.
Brazil is at the center of an outbreak of the Zika virus that has been linked to a surge of brain malformations in newborn babies.
Separately, officials have said the death of a third adult in Brazil had possible links to Zika.
Marcelo Castro announced that Brazil would invest $1.9 million in research for the Zika vaccine over the next five years, in partnership with scientists at the University of Texas.
Researchers have agreed that the testing of the vaccine would happen simultaneously in mice and monkeys, and not separately, to speed up the process, he said.
Photo AFP/Getty Images
A vaccine could be ready for distribution within three years, Marcelo Castro added.
The World Health Organization (WHO) declared a global public health emergency over the possible connection between Zika and microcephaly, a condition marked by abnormally small heads in newborn babies that can result in developmental problems.
The link with Zika has not been confirmed, but the WHO and other public health bodies have said it is strongly suspected.
Brazil has seen more than 4,000 suspected cases of microcephaly since October – a huge surge considering it had fewer than 150 cases in the whole of 2014.
Officials there believe as many as 1.5 million people could be infected by Zika.
Brazil has also announced a partnership with the US Centers for Disease Control and Prevention (CDC) for studies about the possible relation between the virus and the condition.
The microcephaly cases have been centered in north-east Brazil, but the Zika outbreak has affected people in more than 20 countries in the Americas.
Some governments have advised women to delay getting pregnant. Already-pregnant women have been advised not to travel to the countries affected.
Brazilian researchers found the Zika virus in the body of a 20-year-old woman who died last April from respiratory problems in the north-eastern state of Rio Grande do Norte, the health minister said.
Two other patients last year also died from complications while they were infected with the virus, before the outbreak had been discovered.
“We are still studying this in greater detail,” Marcelo Castro said at a press conference.
WHO director general, Margaret Chan, is expected to visit Brazil on February 23, Brazil’s health minister said.
Between three and four million people could be infected with Zika virus in the Americas in 2016, the World Health Organization (WHO) predicts.
Most will not develop symptoms, but the Zika virus, spread by mosquitoes, has been linked to brain defects in babies.
Meanwhile the US says it hopes to start vaccine trials in people by the end of the year.
According to WHO director general Dr. Margaret Chan, Zika had gone “from a mild threat to one of alarming proportions”.
Dr. Margaret Chan has set up a Zika “emergency team” after the “explosive” spread of the virus.
The emergency team will meet on February 1 to decide whether Zika should be treated as a global emergency.
The last time an international emergency was declared was for the Ebola outbreak in West Africa, which has killed more than 11,000 people.
Zika was first detected in Uganda in 1947, but has never caused an outbreak on this scale.
Brazil reported the first cases of Zika in South America in May 2015.
Most cases result in no symptoms and it is hard to test for, but WHO officials said between 500,000 and 1.5 million people had been infected in Brazil.
The virus has since spread to more than 20 countries in the region.
At the same time there has been a steep rise in levels of microcephaly – babies born with abnormally small heads – and the rare nervous system disorder Guillain-Barre syndrome.
The link between the virus and these disorders has not been confirmed, but Dr. Margaret Chan said it was “strongly suspected” and was “deeply alarming”.
She also warned the situation could yet deteriorate as “this year’s El Nino weather patterns are expected to increase mosquito populations greatly in many areas”.
One hospital in Recife, north-east Brazil, had gone from dealing with an average of five cases of microcephaly a year to 300 in the past six months.
Earlier, doctors writing in the Journal of the American Medical Association said Zika had “explosive pandemic potential” and said the WHO’s failure to act swiftly on Ebola probably cost thousands of lives.
In a statement to the executive board meeting of the WHO, Dr. Margaret Chan said: “The level of concern is high, as is the level of uncertainty.
“Questions abound – we need to get some answers quickly.
“For all these reasons, I have decided to convene an Emergency Committee.
“I am asking the Committee for advice on the appropriate level of international concern and for recommended measures that should be undertaken in affected countries and elsewhere.”
Officials from the US National Institute of Health (NIH) said they had two potential Zika vaccines in development.
One that is based on an experimental West Nile vaccine could be repurposed for Zika and enter clinical trials by the end of 2016, Dr. Anthony Fauci from NIH said.
Dr. Anthony Fauci said talks were already taking place with pharmaceutical companies, but a vaccine would not be widely available for several years.
Meanwhile Dr. Anne Schuchat, from the Centers for Disease Control (CDC) confirmed there had been 31 cases of Zika in the US – all linked to travel to the affected areas.
At a news conference, White House spokesman Josh Earnest said the US response to the virus so far had been “consistent with the kind of threat that could be out there”.
“At this point, here in the United States, the risk of a disease spread by mosquitoes is quite low, the January temperatures in North America are quite inhospitable to the mosquito populations.”
“But, obviously that’s going to change,” he added.
Dr. Carissa Etienne, the regional-director for the WHO Pan American Health Organization, said the link between the abnormalities and Zika had not been confirmed.
This website has updated its privacy policy in compliance with EU GDPR 2016/679. Please read this to review the updates about which personal data we collect on our site. By continuing to use this site, you are agreeing to our updated policy. AcceptRejectRead More
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
